SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
ImmunityBio converts from Immunomedics
An SI Board Since February 2023
Posts SubjectMarks Bans Symbol
976 46 0 IBRX
Emcee:  TinfoilHat Type:  Moderated
Introduction Market Data Compact
Investor in IBRX who previously benefited from crowd-sourced knowledge from the moderated Immunomedics forum
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
976Without a big pharma partner the market for Anktiva is growing slower than the mwaitwatchwander-yesterday
975I am starting to think that IBRX has a version of the “AUPH disease”. That is, jargonweary-yesterday
974That’s ok. I still hold GILD. Thanks for the update. They didn’t miss projectiondorightbythem-Thursday
973Sorry I meant to post that on another sitejargonweary-Thursday
972finance.yahoo.comjargonweary-Thursday
971Good questions but longer term the more important question may be- "What wimannamal-Wednesday
970The question now is: Will the combination of Tislelizumab (anti-PD-1) and AnktivHuggenberg2Wednesday
969finance.yahoo.commannamal-Wednesday
968I wonder if Tinfoil might give us his thoughts on the company, it’s leadership ajargonweary3April 17
967Deleted, wrong thread.waitwatchwander-April 16
966The 5 hour Investor's Day presentation reiterated a lot of information aboutEnd2War1April 16
965I have a slight but still nagging concern that our pending drug approval in Eurojargonweary-April 16
964HC Wainwright & Co. analyst Andres Maldonado reiterates ImmunityBio(IBRX) wiluckydog88-April 16
963This is probably the only “blockbuster news”. It was published this morning. ImOlecranon-April 15
962“Investor day is still ongoing fwiw...”. Ah, yes good point. I keep forjargonweary1April 15
961Investor day is still ongoing fwiw...erippetoe-April 15
960If so they must have been misled. Investor day turned out to be a big swing andjargonweary-April 15
959Through question from audience member, PSS was basically saying the FDA was bloczagnut1-April 15
958BTW. They’re on a lunch break until 12:30 PM PST…erippetoe-April 15
957Thanks! Retirement makes you lose track of days!TripleE32April 15
956Investor day is today and is in progress at cts.businesswire.comerippetoe1April 15
955ImmunityBio(IBRX) also reported preliminary net product revenue of about $16.5 mTripleE3-April 15
954Here’s some contact info on the suit: immunitybiosecuritiessettlement.comzagnut1-April 13
953No I have not. This was the only thing I have seen since I first heard about it.bgscolt-April 12
952Thanks Bgscolt. Have you recieved any paperwork to fill out, yet? I have seen galt-April 12
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News